E. NALBAT Et Al. , "Network-based drug repurposing approach identifies novel drugs and drug combinations against HCC," AASLD-TASL Digital Hepatology Meeting , Ankara, Turkey, 2023
NALBAT, E. Et Al. 2023. Network-based drug repurposing approach identifies novel drugs and drug combinations against HCC. AASLD-TASL Digital Hepatology Meeting , (Ankara, Turkey).
NALBAT, E., TUNÇBAĞ, N., KAHRAMAN, D. C., & ATALAY, R., (2023). Network-based drug repurposing approach identifies novel drugs and drug combinations against HCC . AASLD-TASL Digital Hepatology Meeting, Ankara, Turkey
NALBAT, ESRA Et Al. "Network-based drug repurposing approach identifies novel drugs and drug combinations against HCC," AASLD-TASL Digital Hepatology Meeting, Ankara, Turkey, 2023
NALBAT, ESRA Et Al. "Network-based drug repurposing approach identifies novel drugs and drug combinations against HCC." AASLD-TASL Digital Hepatology Meeting , Ankara, Turkey, 2023
NALBAT, E. Et Al. (2023) . "Network-based drug repurposing approach identifies novel drugs and drug combinations against HCC." AASLD-TASL Digital Hepatology Meeting , Ankara, Turkey.
@conferencepaper{conferencepaper, author={ESRA NALBAT Et Al. }, title={Network-based drug repurposing approach identifies novel drugs and drug combinations against HCC}, congress name={AASLD-TASL Digital Hepatology Meeting}, city={Ankara}, country={Turkey}, year={2023}}